Johnson & Johnson - 63 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of May 30, 2025 is 155.21.
  • The all-time high Johnson & Johnson stock closing price was 168.80 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 169.99, which is 9.5% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 140.68, which is 9.4% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 155.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 153.7264 141.6640 166.2770 139.7360 155.2100 9.11%
2024 150.5325 152.5250 163.3320 138.7730 142.2550 -4.81%
2023 150.4521 164.8930 166.7990 137.7210 149.4450 -8.58%
2022 157.5496 154.6750 168.7990 143.5080 163.4680 5.98%
2021 147.3126 137.6450 159.8230 135.4680 154.2510 11.44%
2020 126.4814 124.9860 138.4190 95.7697 138.4190 10.82%
2019 113.8616 106.3860 125.3880 104.6960 124.9000 16.22%
2018 109.2594 112.8840 123.1170 98.1493 107.4690 -5.13%
2017 103.8781 91.5419 115.8520 88.3177 113.2820 24.43%
2016 88.5700 77.2213 97.7644 73.5862 91.0441 15.33%
2015 75.5193 78.0140 80.8871 69.2179 78.9428 1.14%
2014 74.2524 66.1120 80.9996 62.9092 78.0513 17.34%
2013 61.3912 49.9322 69.4528 49.8617 66.5187 34.62%
2012 46.3230 44.7793 50.6683 42.7758 49.4106 10.85%
2011 42.4021 41.2000 45.3374 38.1578 44.5753 9.89%
2010 40.0204 40.9743 42.1496 36.7306 40.5638 -0.59%
2009 36.0280 37.1734 41.1517 28.7988 40.8033 11.27%
2008 39.1830 39.2668 43.9000 33.9127 36.6708 -7.72%
2007 37.6180 38.5730 40.7503 35.0580 39.7375 3.61%
2006 35.7181 34.9791 39.9160 32.2377 38.3522 12.43%
2005 36.3430 35.0076 38.7924 34.0766 34.1107 -3.36%
2004 30.8179 28.1986 35.4862 27.1387 35.2970 25.17%
2003 28.4442 29.6648 31.5850 26.4724 28.1986 -2.08%
2002 30.6850 31.0477 34.7467 22.2796 28.7962 -7.88%
2001 27.3428 26.8059 32.2484 21.8783 31.2593 13.21%
2000 23.4599 24.2271 27.6107 18.0020 27.6107 12.67%
1999 24.7116 21.7305 27.8899 20.2358 24.5063 11.18%
1998 19.7158 17.0986 23.3894 16.8193 22.0425 27.32%
1997 15.6754 13.0744 17.5913 13.0744 17.3121 32.41%
1996 12.7632 11.0705 14.1256 11.0048 13.0744 16.37%
1995 9.0432 7.1613 12.0232 7.0628 11.2348 56.16%
1994 6.0702 5.9458 7.3256 4.8289 7.1942 22.01%
1993 5.5181 6.5043 6.5043 4.6811 5.8966 -11.14%
1992 6.4855 7.3748 7.6458 5.6666 6.6357 -11.79%
1991 5.8899 4.5989 7.5883 4.3115 7.5226 59.58%
1990 4.1289 3.9337 4.8207 3.4163 4.7139 20.84%
1989 3.2884 2.7470 3.9009 2.7470 3.9009 39.50%
1988 2.6598 2.5663 2.8948 2.2831 2.7963 13.69%
1987 2.8312 2.2132 3.4369 2.1188 2.4596 14.09%
1986 2.0929 1.7041 2.4268 1.5686 2.1558 24.71%
1985 1.4631 1.1703 1.7985 1.1538 1.7287 45.67%
1984 1.1264 1.3427 1.3920 0.9280 1.1867 -11.62%
1983 1.5001 1.6261 1.6794 1.2893 1.3427 -17.64%
1982 1.3417 1.2031 1.6753 1.0676 1.6302 33.68%
1981 1.1221 1.0936 1.2647 0.9362 1.2195 11.66%
1980 0.8690 0.8404 1.0950 0.7282 1.0922 25.87%
1979 0.7896 0.8130 0.8760 0.7090 0.8677 7.44%
1978 0.8403 0.8212 0.9718 0.7213 0.8076 -3.90%
1977 0.7704 0.8554 0.8554 0.6857 0.8404 -1.60%
1976 0.9454 0.9868 1.0525 0.7884 0.8541 -13.09%
1975 0.9741 0.9088 1.0840 0.8076 0.9827 10.96%
1974 1.0793 1.2236 1.3017 0.8226 0.8856 -28.27%
1973 1.3016 1.4071 1.4290 1.1443 1.2346 -13.60%
1972 1.2913 1.0704 1.4467 1.0389 1.4290 32.49%
1971 0.9320 0.6269 1.0827 0.6269 1.0786 72.82%
1970 0.5633 0.6406 0.6488 0.4092 0.6241 -5.01%
1969 0.4665 0.3860 0.6570 0.3695 0.6570 69.02%
1968 0.3229 0.3285 0.3887 0.2728 0.3887 16.06%
1967 0.2795 0.2056 0.3495 0.2020 0.3349 61.01%
1966 0.2114 0.2129 0.2433 0.1702 0.2080 -0.76%
1965 0.1689 0.1353 0.2123 0.1353 0.2096 54.12%
1964 0.1278 0.1270 0.1448 0.1168 0.1360 9.59%
1963 0.1093 0.0909 0.1443 0.0903 0.1241 39.28%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $373.447B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $699.116B 53.61
AbbVie (ABBV) United States $328.745B 18.12
Roche Holding AG (RHHBY) Switzerland $257.031B 0.00
Novartis AG (NVS) Switzerland $244.534B 13.96
Merck (MRK) United States $192.948B 9.86
Pfizer (PFE) United States $133.549B 7.32
Sanofi (SNY) France $121.078B 11.93
Bayer (BAYRY) Germany $27.783B 5.66
Innoviva (INVA) United States $1.229B 12.88
Novo Nordisk (NVO) Denmark $0.000B 21.15